Real-time quantitative PCR for toxoplasmosis diagnosis;Apport de la PCR quantitative en réel le diagnostic de la toxoplasmose congénitale

Annales de Biologie Clinique

Volumn 63, Issue 1, 2005, Pages 67-73

  Ordinaire, I ^a   Simon, A ^a   Frealle E ^a,b   Soula, F ^a,b   Valat, A S ^a   Rouland, V ^a   Subtil, D ^a   Dei Cas, E ^a,b   Camus, D ^a,b   Delhaes, L ^a,b  

^a LILLE UNIVERSITY HOSPITAL   (France)

^b INSTITUT PASTEUR DE LILLE   (France)

Author keywords

Antenatal diagnosis; Congenital toxoplasmosis; PCR; Quantitative real time PCR; Toxoplasma gondii

Indexed keywords

PROTOZOAL DNA;

AMNION FLUID; ANIMAL; ARTICLE; CONGENITAL TOXOPLASMOSIS; DISEASE TRANSMISSION; FEMALE; GENETICS; HUMAN; ISOLATION AND PURIFICATION; METHODOLOGY; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PARASITOLOGY; POLYMERASE CHAIN REACTION; PREGNANCY; PREGNANCY COMPLICATION; PRENATAL DIAGNOSIS; TOXOPLASMA;

AMNIOTIC FLUID; ANIMALS; BASE SEQUENCE; DNA, PROTOZOAN; FEMALE; HUMANS; MOLECULAR SEQUENCE DATA; POLYMERASE CHAIN REACTION; PREGNANCY; PREGNANCY COMPLICATIONS, PARASITIC; PRENATAL DIAGNOSIS; TOXOPLASMA; TOXOPLASMOSIS, CONGENITAL;

TOXOPLASMA GONDII;

EID: 13644253912     PISSN: 00033898     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Fortier B, Dao A, Ajana F. Toxoplasme et toxoplasmose. Encyclopédie Médico Chirurgicale, Maladies infectieuses, 8-509-A-10, Pédiatrie, 4-330-A-10. Paris : Elsevier, 2000.
2. Ambroise-Thomas P. Toxoplasmose congénitale : les différentes stratégie préventives. Arch Pediatr 2003; 10 (Suppl. 1): 12-4.
3. Ferret N, Marty P, Le Fichoux Y. Prise en charge clinique de la toxoplasmose congénitale. Arch Pediatr 2003 ; 10 (Suppl. 1) : 42-4.
4. Villena I, Aubert D, Leroux B, et al. Pyrimethamine-sulfadoxine treatment of congenital Toxoplasmosis : follow-up of 78 cases between 1980 and 1997. Scand J Infect Dis 1998 ; 30 : 295-300.
5. Villena I, Chemla C, Aubert D, Foudrinier F, Pinon JM, et le Groupe toxoplasmose de Reims. Toxoplasmose congénitale : diagnostic biologique néonatal et surveillance. Arch Pediatr 2003 ; 10 (Suppl. 1) : 39-41.
6. Robert-Gangneux F, Gavinet MF, Ancelle T, Raymond J, Tourte-Schaefer C, Dupouy-Camet J. Value of prenatal diagnosis and early postnatal diagnosis of congenital toxoplasmosis : retrospective study of 110 cases. J Clin Micmbiol 1999 ; 37 : 2893-8.
7. Costa JM, Pautas C, Ernault P, Foulet F, Cordonnier C, Bretagne S. Real-Time PCR for diagnosis and follow-up of Toxoplasma reactivation after allogenic stem cell transplantation using fluorescence resonance energy transfert hybridation probes. J Clin Microbiol 2000 ; 38 : 2929-32.
8. Costa JM, Ernault P, Gautier E, Bretagne S. Prenatal diagnosis of congenital toxoplasmosis by duplex real-time PCR using fluorescence resonance energy transfer hybridization probes. Prenat Diagn 2001 ; 21 : 85-8.
9. Ambroise-Thomas P, Schweitzer M, Pinon JM, Thiebaugeorges O. La prévention de la toxoplasmose congénitale en France. Bull Acad Natle Med 2001 ; 185 : 665-88.
10. Pinon JM, Dumon H, Chemla C, et al. Strategy for diagnosis of congenital toxoplasmosis : evaluation of methods comparing mothers and newborns and standard methods for postnatal detection of immunoglobulin G, M, and A antibodies. J Clin Microbiol 2001 ; 39 : 2267-71.
11. Burg JL, Grover CM, Pouletty P, Boothroyd JC. Direct and sensitive detection of a pathogenic protozoan, Toxoplasma gondii, by polymerase chain reaction. J Clin Microbiol 1989 ; 27 : 1787-92.
12. Hohlfeld P, Daffos F, Costa JM, Thulliez P, Forestier F, Vidaud M. Prenatal diagnosis of congenital toxoplasmosis with a polymerase-chain-reaction test on amniotic fluid. N Eng l J Med 1994 ; 331 : 695-9.
13. Labalette P, Delhaes L, Margaron F, Fortier B, Rouland JF. Ocular toxoplasmosis after the fifth decade. Am J Ophtaltnol 2002 ; 133 : 506-15.
14. Foulon W, Villena I, Stray-Pedersen B, et al. Treatment of toxoplasmosis during pregnancy : a multicenter study of impact on fetal transmission and children's sequelae at age 1 year. Am J Obstet Gynecol 1999 ; 180 : 410-5.
15. Couvreur J. Le problème de la toxoplasmose congénitale. L'évolution sur quatre décennies. Presse Med 1999 ; 28 : 753-7.
16. Desmonts G, Couvreur J. Étude prospective de l'issue d'une grossesse chez 542 femmes atteintes de toxoplasmose acquise en cours de gestation. Ann Ped 1984 ; 31 : 805-9.
17. Kieffer F, Thulliez P, Brezin A, et al. Traitement de la toxoplasmose congénitale non sévère par sulfadiazine et pyméthamine en continu pendant 1 an : à propos de 46 cas. Arch Pediatr 2002 ; 9 : 7-13.
18. Peyron F, Wallon M, Bernadoux C. Lonf term follow-up of patients with congenital ocular toxoplasmosis. N Engl J Med 1996 ; 334 : 993-4.
19. Circiumaru R, Anton G, Stoian M, Repanovici R. Detection of polynucleotide fragments using hybridization with probes labelled with digoxigenin. Rev Roum Virol 1994 ; 45 : 11-8.
20. Tjalma W, Vanderheyden T, Naessens A, Vanderheyden J, Foulon W. Discordant prenatal diagnosis of congenital toxoplasmosis in a dizygotic pregnancy. Eur J Obstet Gynecol Reprod Biol 1998 ; 79 : 107-8.
21. Romand S, Wallon M, Franck J, Thuilliez P, Peyron F, Dumon H. Prenatal diagnosis using polymerase chain reaction on amniotic fluid for congenital toxoplasmosis. Obstet Gynecol 2001 ; 97 : 296-300.
22. Bretagne S, Costa JM, Foulet F, Jabot-Lestang L, Baud-Camus F, Cordonnier C. Prospective study of Toxoplasma reactivation by polymerase chain reaction in allogenic stem-cell transplant recipients. Transpl Infect Dis 2000 ; 2 : 127-32.
23. Botterel F, Ichai P, Feray C, et al. Disseminated toxoplasmosis, resulting from infection of allograft after orthotopic liver transplantation : usefulness of quantitative PCR. J Clin Microbiol 2002 ; 40 : 1648-50.
24. Cassaing S, Berry A, Bessières MH. Biologie moléculaire et quantification : application en parasitologie. Revue française des laboratoires 2003; 351 : 63-5.
25. Paugam A. Applications de la biologie moléculaire au diagnostic de la toxoplasmose et d'autres protozooses. Revue française des laboratoires 1999 ; 315 : 49-52.